Article Date

At the Bioprodution 2019 Conference in Frankfurt, Germany, Dave Wolton, PM Group, spoke about Adapting Manufacturing Strategies and Facilities to Next Generation Biotherapeutics and Emerging Therapies.

“Cell and Gene therapy facilities are in the process of being scaled up, however it is coming to light that significant headcount is being tied up carrying out routine tasks”, said Dave. “These tasks mainly reside in sampling, sample handling in QC, handling consumables, moving product and moving waste”.  

Dave’s presentation investigated the possibility of using cutting-edge robotics and automation to take over these mundane tasks, and concluded with the realisation that industry wide collaboration is essential.

Contact Dave and our Pharma and Biotherapeutics experts.

Dave Wolton and the Pharma team
Dave Wolton and the Pharma team

Dave Wolton and the Pharma team